Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer.
Rudin CM, Cervantes A, Dowlati A, Besse B, Ma B, Costa DB, Schmid P, Heist R, Villaflor VM, Spahn J, Li S, Cha E, Riely GJ, Gettinger S.
Rudin CM, et al.
ESMO Open. 2023 Apr;8(2):101160. doi: 10.1016/j.esmoop.2023.101160. Epub 2023 Mar 3.
ESMO Open. 2023.
PMID: 36871392
Free PMC article.